| Intelligent Screening and Precision Diagnosis of Prostate Cancer Based on Multimodal Data (NCT07631806) | Guangxi Medical University | 2026-05-01 |
| The Workplace-Based Hypertension Management Program (NCT07265193) | Guangxi Medical University | 2026-01-01 |
| AI Multimodal Model for Liver Cancer Diagnosis and Prognosis (NCT07658586) | Guangxi Medical University | 2025-12-01 |
| AI Multimodal Model for Predicting CRPC Progression Risk (NCT07658573) | Guangxi Medical University | 2025-06-01 |
| Multimodal Imaging and Digital Pathology for Prostate Cancer Prediction (NCT07614256) | Guangxi Medical University | 2025-05-30 |
| A Prospective Study of Cadonilimab in Hepatocellular Carcinoma After Radical Surgery With High Risk of Recurrence (NCT06851104) | Guangxi Medical University | 2025-02-16 |
| Aprepitant Plus Granisetron and Dexamethasone for the Prevention of Vomiting in Patients With HAIC Therapy for HCC (NCT05711823) | Guangxi Medical University | 2024-07-01 |
| Adjuvant Tislelizumab Plus Lenvatinib for Patients at High-risk of HCC Recurrence After Curative Resection or Ablation (NCT05910970) | Guangxi Medical University | 2024-02-15 |
| Fluzoparib With or Without Apatinib in Platinum-sensitive Relapsed Ovarian Cancer Previously Treated With PARPi (NCT06161272) | Guangxi Medical University | 2023-12-10 |
| Cadonilimab in the Treatment of Recurrent/Metastatic Nasopharyngeal Carcinoma (NCT05898256) | Guangxi Medical University | 2023-08-01 |
| HAIC Sequential TAE Combined With Lenvatinib and Tislelizumab in Unresectable HCC (NCT05532319) | Guangxi Medical University | 2022-11-10 |
| Hearing Impairment of Nasopharyngeal Carcinoma (NCT05330169) | Guangxi Medical University | 2022-09-01 |
| PD-1 Inhibitor Plus GP as Neoadjuvant Therapy for Locoregionally Advanced Nasopharyngeal Carcinoma (NCT05340270) | Guangxi Medical University | 2022-07-15 |
| TACE Combined With Tyrosine Kinase Inhibitors and Tislelizumab in Unresectable Hepatocellular Carcinoma (NCT06232759) | Guangxi Medical University | 2022-04-01 |
| Radiofrequency Ablation Plus Radiotherapy for Small Hepatocellular Carcinoma (NCT03988998) | Guangxi Medical University | 2022-01-10 |
| Fruquintinib Plus SOX as Neoadjuvant Therapy for Locally Advanced Gastric Adenocarcinoma (NCT05122091) | Guangxi Medical University | 2021-11-05 |
| Hepatectomy Combined With Camrelizumab and Apatinib in CNLC Stage IIIb HCC (NCT05062837) | Guangxi Medical University | 2021-06-01 |
| Adjuvant Entecavir or Tenofovir for Postoperative HBV-HCC (NCT02650271) | Guangxi Medical University | 2021-02-02 |
| DEB-TACE Plus Lenvatinib or Sorafenib or PD-1 Inhibitor for Unresectable Hepatocellular Carcinoma (NCT04229355) | Guangxi Medical University | 2021-02-02 |
| Effect of Smoked Plum and Chewing Gum on Postoperative Bowel Function Following Hepatic Resection (NCT02649153) | Guangxi Medical University | 2021-01-01 |
| HR Versus RFA for Early Stage HCC (NCT02169765) | Guangxi Medical University | 2020-08-01 |
| Combined Radiotherapy and Radiofrequency Ablation for Hepatocellular Carcinoma (NCT04202523) | Guangxi Medical University | 2019-12-01 |
| Combined Immunotherapy and Targeted Therapy for Advanced Liver Cancer (NCT04163237) | Guangxi Medical University | 2019-12-01 |
| Adjuvant Radiotherapy Comparing TACE for Curative HCC (NCT02125396) | Guangxi Medical University | 2019-05-01 |
| Induction Chemotherapy With Nab-paclitaxel, Cisplatin and Fluorouracil for Locoregionally Advanced Nasopharyngeal Carcinoma (NCT04004871) | Guangxi Medical University | 2019-03-28 |
| Albumin for Hepatocellular Carcinoma (NCT03974074) | Guangxi Medical University | 2019-03-01 |
| Neoadjuvant Radiotherapy for HCC Involving Type I PVTT (NCT04025437) | Guangxi Medical University | 2019-03-01 |
| Adjuvant Therapies for Patients With HCC and MVI (NCT02436902) | Guangxi Medical University | 2019-02-01 |
| Association Between Autologous Transfusion and Recurrence-free Survival in Patients With HCC After Resection (NCT02654028) | Guangxi Medical University | 2019-01-05 |
| Conversion or Neoadjuvant Therapy in Hepatocellular Carcinoma (NCT06405321) | Guangxi Medical University | 2019-01-01 |
| Comparative Study of Human Immunodeficiency Virus Negative Host Talaromyces Between Voriconazole and Amphotericin Sequential Itraconazole Therapy (NCT03827278) | Guangxi Medical University | 2018-12-30 |
| Evaluation of a Psychological Capital Intervention to Alleviate Burnout and Regulate Immunity Among Oncology Nurses (NCT05510414) | Guangxi Medical University | 2018-09-01 |
| The Study of The Treatment of Postoperative Adjuvant Apatinib vs. TACE in Hepatocellular Carcinoma Patients (NCT03511703) | Guangxi Medical University | 2018-05-01 |
| The Study of Apatinib Plus Radiotherapy vs. Apatinib in the Treatment of Hepatocellular Carcinoma With BCLC-C Stage I and Stage II Portal Vein Tumor Thrombus (NCT03520257) | Guangxi Medical University | 2018-05-01 |
| The Value of Pelvic Magnetic Resonance Imaging in Detecting Bone Marrow Infiltration of Lymphoma (NCT03973164) | Guangxi Medical University | 2018-02-02 |
| Radiotherapy in Hepatocellular Carcinomas After Hepatectomy With Narrow Margin (<1 cm) and / or Microvascular Invasion (NCT02678806) | Guangxi Medical University | 2017-11-01 |